Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiodyne was a medical technology company that specialized in the development of non-invasive hemodynamic monitoring systems. The company's flagship product, the CIC-1000, utilized impedance cardiography (ICG) to provide continuous, real-time data on cardiac output and other vital cardiovascular metrics. This technology was positioned as a non-invasive and cost-effective alternative to invasive pulmonary artery catheterization, particularly for managing patients with congestive heart failure and hypertension. Despite its early innovation in the ICG field, the company faced significant competition and legal hurdles, eventually leading to its dissolution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiodyne Electronics.